Regenerative Aesthetics: Separating the Category From the Marketing
"Regenerative" has become the most commercially useful word in aesthetics, and it now covers treatments that share a marketing category rather than a mechanism. Understanding what actually sits underneath it is the difference between offering a considered service and repeating a distributor's slide deck.
Three different things
Platelet-rich plasma is the patient's own blood, processed to concentrate platelets, then reinjected. The proposition is that platelet-derived growth factors stimulate repair. It is autologous, which removes the question of foreign material, and it introduces an entirely different set of obligations: taking, handling and reinjecting human blood.
Polynucleotides are purified DNA fragments, usually of fish origin, injected to improve skin quality. They are not volumising and should not be sold as such — the claim is hydration, elasticity and tissue quality rather than shape.
Collagen biostimulators — poly-L-lactic acid and calcium hydroxylapatite among them — provoke the body to lay down its own collagen over months. They occupy a genuine middle ground between filler and skin treatment, and they behave quite differently from hyaluronic acid in two ways that matter enormously.
The two facts about biostimulators every injector must hold
First, the result is delayed. Nothing meaningful is visible immediately, improvement develops over months, and a patient expecting a filler-like change on the day will conclude the treatment failed. This must be established before treatment, not explained afterwards.
Second, and far more important: they are not reversible. Hyaluronidase does nothing to them. Every safety habit that hyaluronic acid injectors have built around the possibility of undoing a mistake does not apply here, and a nodule or an over-treated area is a problem to be managed over time rather than dissolved [3].
That single fact should change who treats with them and how conservatively. An injector whose confidence rests on reversibility is not ready for a product without it.
Handling and regulation
PRP is the outlier. It involves drawing, processing and reinjecting human blood, which brings quality and safety obligations, staff training, and a standard of aseptic handling higher than an ordinary injectable appointment. Kits and centrifuges are regulated devices, and the manufacturer's protocol is not a suggestion — deviating from it produces preparations that differ from anything the evidence describes [1].
National rules on who may perform PRP, and under what conditions, vary. It is worth establishing that position locally rather than assuming a course certificate settles it.
Biostimulators and polynucleotides carry their own preparation and reconstitution requirements, and the recorded batch and lot of every product used belongs in the notes as it does for any injectable [2].
What the evidence supports, and what it does not
The honest position is that this category shows real but modest benefits in skin quality and, for biostimulators, genuine volume restoration over time — and that the quality of evidence varies considerably between the three, with PRP protocols differing so much between clinics that comparing studies is difficult.
None of them regenerate tissue in the sense the word implies to a patient. None reverse ageing. A patient who has read the marketing believes they are buying something categorically different from a filler; what they are usually buying is a slower, subtler change that requires a course and maintenance.
Describing it honestly
The conversation that produces satisfied patients is straightforward: this improves skin quality rather than shape; results develop over months, not days; a course is needed and maintenance after that; and — for biostimulators — it cannot be undone, so we will proceed conservatively.
Patients are not disappointed by modest claims accurately delivered. They are disappointed by large claims partially delivered, which is the failure mode this category invites.
The professional point
Regenerative treatments are a legitimate addition to a practice and a poor place to be casual. The irreversibility of biostimulators in particular belongs in the same mental category as the nose: a region of practice you enter deliberately, after specific training, rather than because a supplier offered a good margin.